10 (1.34%)
Oocyte meiosis
14 (1.88%)
Adherens junction
16 (2.15%)
Cell cycle
17 (2.28%)
p53 signaling pathway
20 (2.68%)
Lysosome
20 (2.68%)
Tight junction
35 (4.70%)
Regulation of actin cytoskeleton
35 (4.70%)
Phagosome
4 (0.54%)
Peroxisome
51 (6.85%)
Focal adhesion
51 (6.85%)
Endocytosis
56 (7.52%)
Apoptosis
9 (1.21%)
Gap junction
Cellular Processes
1 (0.13%)
Hippo signaling pathway
1 (0.13%)
Jak-STAT signaling pathway
1 (0.13%)
cGMP-PKG signaling pathway
1 (0.13%)
PI3K-Akt signaling pathway
11 (1.48%)
Phosphatidylinositol signaling system
13 (1.74%)
Notch signaling pathway
15 (2.01%)
Hedgehog signaling pathway
16 (2.15%)
VEGF signaling pathway
17 (2.28%)
ECM-receptor interaction
2 (0.27%)
AMPK signaling pathway
23 (3.09%)
ErbB signaling pathway
25 (3.36%)
Calcium signaling pathway
28 (3.76%)
Wnt signaling pathway
29 (3.89%)
TGF-beta signaling pathway
34 (4.56%)
Cell adhesion molecules (CAMs)
35 (4.70%)
mTOR signaling pathway
36 (4.83%)
Neuroactive ligand-receptor interaction
36 (4.83%)
FoxO signaling pathway
5 (0.67%)
ABC transporters
80 (10.74%)
MAPK signaling pathway
92 (12.35%)
Cytokine-cytokine receptor interaction
Environmental Information Processing
1 (0.13%)
Ribosome
1 (0.13%)
Sulfur relay system
14 (1.88%)
Ubiquitin mediated proteolysis
16 (2.15%)
RNA transport
2 (0.27%)
Fanconi anemia pathway
2 (0.27%)
SNARE interactions in vesicular transport
2 (0.27%)
Ribosome biogenesis in eukaryotes
34 (4.56%)
Protein processing in endoplasmic reticulum
4 (0.54%)
Protein export
5 (0.67%)
Aminoacyl-tRNA biosynthesis
8 (1.07%)
mRNA surveillance pathway
9 (1.21%)
Spliceosome
9 (1.21%)
RNA degradation
Genetic Information Processing
1 (0.13%)
Melanoma
1 (0.13%)
Small cell lung cancer
1 (0.13%)
Hepatitis B
1 (0.13%)
HTLV-I infection
1 (0.13%)
Colorectal cancer
1 (0.13%)
Toxoplasmosis
1 (0.13%)
Influenza A
1 (0.13%)
Viral myocarditis
1 (0.13%)
Legionellosis
1 (0.13%)
Acute myeloid leukemia
1 (0.13%)
Endometrial cancer
1 (0.13%)
Thyroid cancer
1 (0.13%)
Epstein-Barr virus infection
1 (0.13%)
Central carbon metabolism in cancer
1 (0.13%)
Glioma
1 (0.13%)
Viral carcinogenesis
1 (0.13%)
Pancreatic cancer
1 (0.13%)
Bladder cancer
1 (0.13%)
Endocrine resistance
1 (0.13%)
Pathways in cancer
1 (0.13%)
Non-small cell lung cancer
1 (0.13%)
Chronic myeloid leukemia
1 (0.13%)
Prostate cancer
1 (0.13%)
MicroRNAs in cancer
1 (0.13%)
Proteoglycans in cancer
2 (0.27%)
Measles
25 (3.36%)
Salmonella infection
52 (6.98%)
AGE-RAGE signaling pathway in diabetic complications
66 (8.86%)
Herpes simplex infection
Human Diseases
1 (0.13%)
Folate biosynthesis
1 (0.13%)
Tryptophan metabolism
1 (0.13%)
Glycolysis / Gluconeogenesis
1 (0.13%)
2-Oxocarboxylic acid metabolism
1 (0.13%)
Glycosphingolipid biosynthesis - ganglio series
1 (0.13%)
Linoleic acid metabolism
1 (0.13%)
Tyrosine metabolism
1 (0.13%)
Glyoxylate and dicarboxylate metabolism
1 (0.13%)
Phenylalanine metabolism
1 (0.13%)
Caffeine metabolism
1 (0.13%)
D-Glutamine and D-glutamate metabolism
1 (0.13%)
Phenylalanine, tyrosine and tryptophan biosynthesis
1 (0.13%)
alpha-Linolenic acid metabolism
11 (1.48%)
Arginine and proline metabolism
11 (1.48%)
Glycerophospholipid metabolism
14 (1.88%)
Glycerolipid metabolism
14 (1.88%)
Purine metabolism
18 (2.42%)
Sphingolipid metabolism
2 (0.27%)
One carbon pool by folate
2 (0.27%)
Metabolism of xenobiotics by cytochrome P450
2 (0.27%)
Drug metabolism - cytochrome P450
2 (0.27%)
Other types of O-glycan biosynthesis
2 (0.27%)
Glycosaminoglycan degradation
2 (0.27%)
Biosynthesis of unsaturated fatty acids
2 (0.27%)
Ascorbate and aldarate metabolism
2 (0.27%)
Fatty acid elongation
2 (0.27%)
Selenocompound metabolism
2 (0.27%)
Terpenoid backbone biosynthesis
3 (0.40%)
Glycosaminoglycan biosynthesis - keratan sulfate
3 (0.40%)
Steroid hormone biosynthesis
3 (0.40%)
Pentose and glucuronate interconversions
3 (0.40%)
Sulfur metabolism
3 (0.40%)
Porphyrin and chlorophyll metabolism
3 (0.40%)
Starch and sucrose metabolism
3 (0.40%)
Drug metabolism - other enzymes
3 (0.40%)
Galactose metabolism
3 (0.40%)
Glycosphingolipid biosynthesis - lacto and neolacto series
3 (0.40%)
Lysine degradation
4 (0.54%)
Cysteine and methionine metabolism
4 (0.54%)
Fatty acid degradation
4 (0.54%)
Nicotinate and nicotinamide metabolism
4 (0.54%)
Fatty acid biosynthesis
4 (0.54%)
Pantothenate and CoA biosynthesis
4 (0.54%)
Pentose phosphate pathway
4 (0.54%)
Fructose and mannose metabolism
5 (0.67%)
Glycine, serine and threonine metabolism
5 (0.67%)
Ether lipid metabolism
5 (0.67%)
Amino sugar and nucleotide sugar metabolism
5 (0.67%)
Primary bile acid biosynthesis
5 (0.67%)
N-Glycan biosynthesis
5 (0.67%)
Alanine, aspartate and glutamate metabolism
5 (0.67%)
Arginine biosynthesis
5 (0.67%)
beta-Alanine metabolism
6 (0.81%)
Taurine and hypotaurine metabolism
6 (0.81%)
Arachidonic acid metabolism
6 (0.81%)
Carbon metabolism
6 (0.81%)
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate
6 (0.81%)
Biosynthesis of amino acids
6 (0.81%)
Pyrimidine metabolism
6 (0.81%)
Mucin type O-Glycan biosynthesis
6 (0.81%)
Fatty acid metabolism
7 (0.94%)
Oxidative phosphorylation
7 (0.94%)
Glycosaminoglycan biosynthesis - heparan sulfate / heparin
8 (1.07%)
Glutathione metabolism
8 (1.07%)
Inositol phosphate metabolism
9 (1.21%)
Retinol metabolism
Metabolism
1 (0.13%)
Thyroid hormone signaling pathway
1 (0.13%)
Salivary secretion
1 (0.13%)
Prolactin signaling pathway
1 (0.13%)
Oxytocin signaling pathway
1 (0.13%)
Bile secretion
1 (0.13%)
Antigen processing and presentation
1 (0.13%)
Longevity regulating pathway - multiple species
1 (0.13%)
Estrogen signaling pathway
11 (1.48%)
Melanogenesis
12 (1.61%)
GnRH signaling pathway
12 (1.61%)
Intestinal immune network for IgA production
13 (1.74%)
PPAR signaling pathway
13 (1.74%)
Progesterone-mediated oocyte maturation
18 (2.42%)
Vascular smooth muscle contraction
21 (2.82%)
Cytosolic DNA-sensing pathway
24 (3.22%)
Insulin signaling pathway
29 (3.89%)
Adrenergic signaling in cardiomyocytes
31 (4.16%)
NOD-like receptor signaling pathway
34 (4.56%)
Adipocytokine signaling pathway
35 (4.70%)
RIG-I-like receptor signaling pathway
5 (0.67%)
Cardiac muscle contraction
51 (6.85%)
Toll-like receptor signaling pathway
7 (0.94%)
Dorso-ventral axis formation
Organismal Systems
0%
10%
20%
Annotated Genes